Bacteriophage and antibiotic combination therapy for recurrent Enterococcus faecium bacteremia
ABSTRACTEnterococcus faecium is a member of the human gastrointestinal (GI) microbiota but can also cause invasive infections, especially in immunocompromised hosts. Enterococci display intrinsic resistance to many antibiotics, and most clinical E. faecium isolates have acquired vancomycin resistanc...
Main Authors: | Madison E. Stellfox, Carolyn Fernandes, Ryan K. Shields, Ghady Haidar, Kailey Hughes Kramer, Emily Dembinski, Mihnea R. Mangalea, Garima Arya, Gregory S. Canfield, Breck A. Duerkop, Daria Van Tyne |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2024-03-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.03396-23 |
Similar Items
-
Empyema thoracis in a patient with Enterococcus faecium Bacteremia
by: Chee Yik Chang
Published: (2020-05-01) -
Assessing Clinical Outcomes of Vancomycin Treatment in Adult Patients with Vancomycin-Susceptible <i>Enterococcus faecium</i> Bacteremia
by: Hiroshi Sasano, et al.
Published: (2023-10-01) -
The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections
by: Olaniyi Ayobami, et al.
Published: (2020-01-01) -
Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report
by: Chen P, et al.
Published: (2023-03-01) -
Biological characteristics and anti-biofilm activity of a lytic phage against vancomycin-resistant Enterococcus faecium
by: Forough Goodarzi, et al.
Published: (2021-10-01)